Regulatory bodies impact cancer treatment by ensuring that new therapies are safe and effective before they reach the market. They review clinical trial data and approve or reject new drugs based on evidence of their benefits and risks. This rigorous process helps protect patients from ineffective or harmful treatments. Additionally, they monitor post-market safety to identify any long-term side effects or issues.
